Arkolith/Insider Trading/PTIX/Form 4

Arrow Alexander K.

Chief Financial OfficerProtagenic Therapeutics, Inc. ew (PTIX) · full profile →Form 4 · filed May 18, 2022
Net Buying
Open-Market Buys
$22K
Open-Market Sells
$0
Net Open-Market Flow
$22K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 18, 2022Buy(P)8K$0.72$6K151K
May 17, 2022Buy(P)23K$0.71$16K143K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-014338) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML